Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

'Moonshot' Pilot Aims To Fast Track Cancer Immunotherapy Patents

Executive Summary

The Obama administration is offering biopharmaceutical companies and other inventors of cancer immunotherapies the opportunity to get their patent applications examined within 12 months under a special accelerated pilot program as part of the White House's $1bn National Cancer Moonshot initiative.


Related Content

Unifying On Immunotherapy: Will It Pay Off?
Can 'Moon Shot' Lift FDA Out Of Its Silos?
FDA 'Moon Shot' Center To Expedite Combo Cancer Drugs
'Moon Shot' Confusion? NIH Chief Provides Clarity
Obama/Biden: Science Ready For Cancer 'Moon Shot'